Instituto De Investigación Biomédica De Salamanca
Clinical trials sponsored by Instituto De Investigación Biomédica De Salamanca, explained in plain language.
-
Eye stem cell trial offers hope for transplant patients with crippling dry eye
Disease control Not yet recruitingThis study tests if injecting stem cells into the eye can help people with severe dry eye caused by graft-versus-host disease (GVHD), a complication of bone marrow transplants. About 30 adults who have not improved with standard treatments will receive either one or two doses of …
Phase: PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated May 26, 2026 04:26 UTC
-
Simple urine test could spot kidney disease early and monitor treatment success
Knowledge-focused Not yet recruitingThis study will follow 300 adults with chronic kidney disease to see how well a urine test can detect early signs of kidney damage and track disease progression. Researchers will also observe how common medications called SGLT2 inhibitors (like empagliflozin) affect kidney functi…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated May 26, 2026 04:30 UTC
-
Blood protein clues could spot dangerous infections in cancer patients early
Knowledge-focused Not yet recruitingThis study is for adults with blood cancer who develop a fever and have very low white blood cells, a condition called febrile neutropenia. Researchers will analyze blood samples from 350 patients to find protein patterns that may predict serious complications like sepsis. The go…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
New combo test aims to spot hidden heart risk after attack
Knowledge-focused Not yet recruitingThis study looks at 95 people who had a severe heart attack to see if combining a special CT scan with a blood test for tiny molecules (miRNAs) can better predict long-term heart damage. The goal is to identify who is at high risk for heart failure so they can get closer monitori…
Phase: NA • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC